Apellis Pharmaceuticals Inc (APLS) — Capital Reinvestment Ratio
Apellis Pharmaceuticals Inc (APLS) has a Capital Reinvestment Ratio of 0.00x as of September 2025, meaning it reinvests 0% of its operating cash flow ($108.47 Million) in capital expenditures ($148.00K). Check tangible net worth ratio of Apellis Pharmaceuticals Inc to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Apellis Pharmaceuticals Inc Capital Reinvestment Ratio (2025–2025)
This chart tracks Apellis Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see APLS operating cash flow.
Annual Capital Reinvestment Ratio for Apellis Pharmaceuticals Inc (2025–2025)
Year-by-year Capital Reinvestment Ratio for Apellis Pharmaceuticals Inc from 2025 to 2025. See Apellis Pharmaceuticals Inc (APLS) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | $45.33 Million | $313.00K | — |